Search for: "BRISTOL-MYERS SQUIBB"
Results 741 - 760
of 866
Sorted by Relevance
|
Sort by Date
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline,… [read post]
8 Mar 2010, 7:49 am
., Eastman Chemical, Safeway, Dow Chemical, Pfizer, Chevron, Bristol-Myers Squibb, and Time Warner. [read post]
31 Jan 2009, 6:54 am
• Bristol-Myers Squibb posted a quarterly profit of $1.24 billion. [read post]
21 Jun 2017, 4:26 am
” Briefly: At The George Washington Law Review’s On the Docket blog, Alan Morrison looks at Monday’s decision in Bristol-Myers Squibb Co. v. [read post]
9 Nov 2010, 10:33 am
While publication to the scientific community is not the same as disclosure to the PTO and does not foreclose a finding of deceptive intent, see Bristol-Myers Squibb Co. v. [read post]
17 Nov 2010, 1:48 am
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Fipronil – UK:… [read post]
25 Mar 2021, 11:33 am
With Specific Jurisdiction, the Court’s recent decision in Bristol-Myers Squibb Co. v. [read post]
21 Jun 2010, 9:57 am
They ask as follows: "(i) Are Article 7(2) of [the repealed and re-enacted but regularly cited] Council Directive 89/104 ... to approximate the laws of the Member States relating to trade marks and the associated case-law, in particular the judgments of the Court of Justice in Cases 102/77 Hoffmann-La Roche v Centrafarm and 1/81 Pfizer v Eurim-Pharm and Joined Cases C-427/93, C-429/93 and C-436/93 Bristol-Myers Squibb and Others v Paranova, to be interpreted as… [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
13 Feb 2023, 2:40 pm
EU/1/15/1014 for nivolumab, granted to Bristol-Myers Squibb Pharma GEIE. [read post]
18 Jan 2017, 7:35 am
Bristol-Myers Squibb Co. v. [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
29 Sep 2008, 8:14 pm
Universities Allied for Essential Medicines (UAEM)1 is a non-profit organization that works with faculty and student groups to help ensure the availability of essential medicines in poor countries.2 Among other activities, UAEM hopes to persuade universities to commit to the principle that when they license university-developed medical-related technologies to private companies, a condition of the license will be that the private company agree to make medicines that are created using the… [read post]
18 Jan 2017, 10:19 am
(relisted after the January 6 and January 13 conferences) Bristol-Myers Squibb Co. v. [read post]
11 Aug 2024, 5:47 pm
(Mirati), a Bristol Myers Squibb company, on August 1, 2024 for content on a healthcare provider branded website for its product, KRAZATI (adagrasib), which was approved under FDA’s accelerated approval pathway for patients with certain types of non-small cell lung cancer based on objective response rate (ORR) and duration of response (DOR). [read post]
13 May 2010, 12:27 pm
Bristol-Myers Squibb Co., 2009 WL 5216984 (D.N.J. [read post]
16 Jun 2014, 4:45 am
See Bristol-Myers Squibb Co. v. [read post]
17 May 2021, 1:12 pm
“And Trimble is headquartered in California, connecting California to Trimble’s claims, which is a consideration the Court in Ford found relevant in distinguishing its earlier decision in Bristol-Myers. [read post]
15 Dec 2008, 2:00 pm
Shortly after the drug hit the market, Sanofi-Synthelabo, which owns the Plavix patent, and Bristol-Myers Squibb, owner of the Plavix marketing rights, sought and obtained an injunction barring sales of the generic. [read post]
5 Oct 2020, 9:01 pm
Should the Court now adopt a restrictive interpretation of the phrase “arises out of or relate to,” it would limit specific personal jurisdiction in a way that would benefit corporate manufacturers at the expense of consumers.Justice Sonia Sotomayor articulated this concern in her dissent in Bristol-Myers Squibb v. [read post]
